Around the Region
Cubist appoints a new president
Cubist Pharmaceuticals Inc. said Monday that executive vice president and chief operating officer Robert J. Perez has been named President and COO. The Lexington-based biopharmaceutical company makes an intravenous antibiotic called Cubicin. As president and COO, Perez will oversee all global commercial, manufacturing, business development, and information technology functions. In this capacity, he will have responsibility for overseeing Cubist’s international business expansion.